| |
| |
|
| Insider
Information: |
Dhillon Avtar S |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
13,835,427 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$357,048 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,835,427 |
|
|
| Total
Value |
$357,048 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Inovio Biomedical Corp |
INO |
Director |
2018-12-06 |
106,002 |
2004-09-14 |
0 |
Premium* |
|
|
Oncosec Medical Incorporation |
ONCS |
Director |
2020-04-17 |
62,052 |
|
0 |
Premium* |
|
|
Stevia First Corp |
STVF |
Director, 10% Owner |
2012-02-14 |
5,150,000 |
|
0 |
Premium* |
|
|
Arch Therapeutics, Inc. |
ARTH |
Director |
2018-07-19 |
8,517,373 |
2013-06-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2020-04-17 |
4 |
A |
$1.55 |
$19,375 |
D/D |
12,500 |
62,052 |
0 |
- |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2018-12-06 |
4 |
OE |
$2.00 |
$50,000 |
D/D |
25,000 |
106,002 |
0 |
- |
|
| ARTH |
Arch Therapeutics, Inc. |
Director |
– • – |
2018-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
220,000 |
8,517,373 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2018-07-05 |
4 |
S |
$1.31 |
$4,067 |
D/D |
(3,100) |
143,427 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2018-06-29 |
4 |
S |
$1.38 |
$1,471 |
D/D |
(1,066) |
146,527 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2018-06-28 |
4 |
S |
$1.40 |
$2,180 |
D/D |
(1,556) |
147,593 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2018-06-27 |
4 |
S |
$1.37 |
$4,742 |
D/D |
(3,451) |
149,149 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2018-06-26 |
4 |
S |
$1.40 |
$6,575 |
D/D |
(4,703) |
152,600 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2018-06-25 |
4 |
S |
$1.41 |
$284 |
D/D |
(202) |
157,303 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2018-06-22 |
4 |
S |
$1.42 |
$4,192 |
D/D |
(2,956) |
157,505 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2018-06-21 |
4 |
S |
$1.40 |
$3,051 |
D/D |
(2,178) |
160,461 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2018-06-20 |
4 |
S |
$1.42 |
$15,604 |
D/D |
(10,973) |
162,639 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2018-06-19 |
4 |
S |
$1.36 |
$2,507 |
D/D |
(1,838) |
173,612 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2018-06-18 |
4 |
S |
$1.39 |
$7,695 |
D/D |
(5,552) |
175,450 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2018-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
100,000 |
181,002 |
0 |
- |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2018-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,669 |
81,002 |
0 |
- |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2017-05-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
73,333 |
0 |
- |
|
| ARTH |
Arch Therapeutics, Inc. |
Director |
– • – |
2017-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
400,000 |
8,297,373 |
0 |
- |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2016-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
63,333 |
0 |
- |
|
| ARTH |
Arch Therapeutics, Inc. |
Director |
– • – |
2016-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
737,000 |
7,897,373 |
0 |
- |
|
| ONCS |
Oncosec Medical Incorpora... |
Director |
– • – |
2015-10-16 |
4 |
B |
$4.36 |
$43,590 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| ARTH |
Arch Therapeutics, Inc. |
Director |
– • • |
2013-06-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,000,000 |
|
- |
|
| ARTH |
Arch Therapeutics, Inc. |
Director |
– • • |
2013-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
160,373 |
7,160,373 |
0 |
- |
|
| STVF |
Stevia First Corp |
Director |
– • • |
2012-02-14 |
4 |
S |
$0.00 |
$52,311 |
D/D |
(23,777,500) |
5,150,000 |
0 |
- |
|
| STVF |
Stevia First Corp |
Director |
– • • |
2012-02-03 |
4 |
S |
$0.00 |
$5,660 |
D/D |
(2,572,500) |
28,927,500 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
